Cargando…

Air Pollution and Type 2 Diabetes: Mechanistic Insights

Detalles Bibliográficos
Autores principales:	Rajagopalan, Sanjay, Brook, Robert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Perspectives in Diabetes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501850/ https://www.ncbi.nlm.nih.gov/pubmed/23172950 http://dx.doi.org/10.2337/db12-0190

Ejemplares similares

Getting Sympathetic About Air Pollution Exposure
por: Brook, Robert D., et al.
Publicado: (2021)

Learning From Molecular Genetics: Novel Insights Arising From the Definition of Genes for Monogenic and Type 2 Diabetes
por: McCarthy, Mark I., et al.
Publicado: (2008)

Hypoglycemia in Type 1 Diabetes
por: McCrimmon, Rory J., et al.
Publicado: (2010)

The Role of TCF7L2 in Type 2 Diabetes
por: del Bosque-Plata, Laura, et al.
Publicado: (2021)

Islets in Type 2 Diabetes: In Honor of Dr. Robert C. Turner
por: Bonner-Weir, Susan, et al.
Publicado: (2008)

Central Role for Interleukin-2 in Type 1 Diabetes
por: Hulme, Maigan A., et al.
Publicado: (2012)

Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
por: Sellmeyer, Deborah E., et al.
Publicado: (2016)

Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015)

A Global Overview of Precision Medicine in Type 2 Diabetes
por: Fitipaldi, Hugo, et al.
Publicado: (2018)

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man
por: Skyler, Jay S., et al.
Publicado: (2011)

Ambient Air Pollution and Atherosclerosis: Recent Updates
por: Bevan, Graham H., et al.
Publicado: (2021)

Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes
por: Ling, Charlotte, et al.
Publicado: (2009)

Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus
por: Sapkota, Lokendra Bahadur, et al.
Publicado: (2017)

The Streetlight Effect in Type 1 Diabetes
por: Battaglia, Manuela, et al.
Publicado: (2015)

The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM)
por: Kelly, Katherine, et al.
Publicado: (2016)

Culture-centered approaches: the relevance of assessing emotional health for Latinos with type 2 diabetes
por: Concha, Jeannie Belinda, et al.
Publicado: (2015)

Flattening the curve in COVID-19 using personalised protective equipment: lessons from air pollution
por: Rajagopalan, Sanjay, et al.
Publicado: (2020)

Genetics of Type 1 Diabetes: What's Next?
por: Pociot, Flemming, et al.
Publicado: (2010)

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1
por: Sosenko, Jay M., et al.
Publicado: (2012)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Antigen-Based Therapy for the Treatment of Type 1 Diabetes
por: Tian, Jide, et al.
Publicado: (2009)

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
por: Linsley, Peter S., et al.
Publicado: (2021)

Efficacy of Metreleptin in Obese Patients With Type 2 Diabetes: Cellular and Molecular Pathways Underlying Leptin Tolerance
por: Moon, Hyun-Seuk, et al.
Publicado: (2011)

Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function?
por: Meier, Juris J., et al.
Publicado: (2010)

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?
por: Costes, Safia, et al.
Publicado: (2013)

Anatomical Locations of Human Brown Adipose Tissue: Functional Relevance and Implications in Obesity and Type 2 Diabetes
por: Sacks, Harold, et al.
Publicado: (2013)

Protein Kinase C Function in Muscle, Liver, and β-Cells and Its Therapeutic Implications for Type 2 Diabetes
por: Schmitz-Peiffer, Carsten, et al.
Publicado: (2008)

Metformin and SARS-CoV-2: mechanistic lessons on air pollution to weather the cytokine/thrombotic storm in COVID-19
por: Menendez, Javier A.
Publicado: (2020)

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
por: Tuttle, Katherine R., et al.
Publicado: (2021)

The Clinical Potential of C-Peptide Replacement in Type 1 Diabetes
por: Wahren, John, et al.
Publicado: (2012)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

The Evolving Landscape of Autoantigen Discovery and Characterization in Type 1 Diabetes
por: Purcell, Anthony W., et al.
Publicado: (2019)

Indian Phenotype Characteristics Among Patients with Type 2 Diabetes Mellitus: Insights from a Non-interventional Nationwide Registry in India
por: Kalra, Sanjay, et al.
Publicado: (2022)

The effect of macrobiotic Ma-Pi 2 diet on systemic inflammation in patients with type 2 diabetes: a post hoc analysis of the MADIAB trial
por: Soare, Andreea, et al.
Publicado: (2015)

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?
por: Akirav, Eitan, et al.
Publicado: (2008)

It’s Time to Bring Dendritic Cell Therapy to Type 1 Diabetes
por: Creusot, Rémi J., et al.
Publicado: (2014)

Posttranslational Modifications of Proteins in Type 1 Diabetes: The Next Step in Finding the Cure?
por: Dunne, Jessica L., et al.
Publicado: (2012)

The American Diabetes Association Diabetes Research Perspective
por: Fonseca, Vivian A., et al.
Publicado: (2012)

Immunomodulation by Mesenchymal Stem Cells : A Potential Therapeutic Strategy for Type 1 Diabetes
por: Abdi, Reza, et al.
Publicado: (2008)

From Pancreatic β-Cell Gene Networks to Novel Therapies for Type 1 Diabetes
por: Eizirik, Decio L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g3s0lj3urhggeq45dhefps6er5